Fortune August 22, 2024
Ani Freedman

Drugs like Ozempic and Wegovy—also known as glucagon-like peptide-1 (GLP-1) or semaglutide medications—have been linked to increased suicidal thoughts, says a new study published in JAMA Network Open on Aug. 20.

“A detected signal of semaglutide-associated suicidal ideation warrants urgent clarification,” the academic researchers noted in the study.

Using an expansive World Health Organization database of reported individual adverse reactions to medications, they conducted a disproportionality analysis of GLP-1 RAs semaglutide and liraglutide, looking for observations of suicidal thoughts, and found such thoughts to be greater than expected.

What they found was a 45% greater rate of reports of suicidal thoughts associated with semaglutide than with all the other drugs in the database.

Mixed findings in semaglutide studies

It’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Patient / Consumer, Pharma / Biotech, Provider, Trends
How Life Sciences Can Drive Innovation And Sustainability In Returns Management
How Americans feel about weight-loss drugs, in 3 charts
Tariffs on China threaten could drive up drug costs, exacerbate shortages: 5 notes
Drugmakers prep for bird flu outbreak, despite continued low risk
Heart health differences in men and women: Tiny RNA molecules play key role, study finds

Share This Article